Responsiveness to recombinant human erythropoetin (rh-Epo) of marrow erythroid progenitors (CFU-E and BFU-E) from B-chronic lymphocytic leukemia (B-CLL)

Journal of Experimental and Clinical Cancer Research

Volumn 16, Issue 2, 1997, Pages 163-170

  Tsatalas, C ^a,b   Chalkia, P ^a   Tsantali, Ch ^a   Kakoulidis, I ^a   Garyfallos, A ^a   Klonizakis, I ^a   Panayiotopoulos, S ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

B CLL; BFU E; CFU E

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BONE MARROW CELL; BURST FORMING UNIT E; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT E; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL;

AGED; BONE MARROW; BONE MARROW CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 0030962823     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Winearls C.G., Oliver D.O., Pippard M.J., Reid C., Downing R., Cotes P.M.: Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet ii: 1175-7, 1986.
2. Eschbach J.W., Egrie J.C., Downing M.R., Browne J.K., Adamson J.W.: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N. Engl. J. Med. 316: 73-8, 1987.
3. Eschbach J.W., Kelly M.R., Haley N.R., Abels R.I., Adamson J.W.:. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N. Engl. J. Med. 321: 158-63, 1989.
4. Oster W., Herrmann F., Gamm H., et al.: Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J. Clin. Oncol. 8: 956-62, 1990.
5. Ludwig H., Fritz E., Kotzmann H., Hocker P., Gisslinger H., Barnas U.: Erythropoietin treatment of anemia associated with multiple myeloma. N. Engl. J. Med. 322: 1693-9, 1990.
6. Barlogie B., Beck T.: Recombinant human erythropoietin and the anemia of multiple myeloma. Stem Cells I 1: 95-104, 1993.
7. Bessho M., Jinnai I., Matsuda A., Saito M., Hiroshima K.: Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Int. J. Cell Cloning 8: 445-58, 1990.
8. Stebler C., Tichelli A., Dazzi H., Gratwohl A., Nissen C., Speck B.: High- dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: A pilot study. Exp. Hematol. 18: 1204-8, 1990.
9. Bowen D., Culligan D., Jacobs A.: The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin. Br. J. Haematol. 77: 419-23, 1991.
10. Hellstrom E., Birgegard G., Lockner D., Ost A., Wide L.: Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Eur. J. Haematol. 47: 355-60, 1991.
11. Abels R.I., Larholt K.M., Krantz K.D., Bryant E.C.: Recombinant human erythropoietin (rHuEPO) for the treatment of the anemia of cancer. In: MURPHY MJ Jr, ed. Blood cell growth factors: Their present and future use in hematology and oncology. Beijing Symposium. Dayton, OH, Alpha Med. Press 121-41, 1991.
12. Spivak J.L. Editorial: Recombinant human erythropoietin and the anemia of cancer. Blood 84: 997-1004, 1997.
13. Pangalis G.A., Poziopoulos C., Angelopoulou M.K., Siakantaris M.P., Panayiotidis P.: Effective treatment of disease-related anaemia in B-chronic Iympocytic leukaemia patients with recombinant human erythropoietin. Br. J. Haematol. 89:627-9, 1995.
14. Ludwig H., Fritz E., Leitgeb C., Pecherstorfer M., Samonigg H., Schuster J.: Prediction of response to erythropoietin treatment in chronic anemia of cancer. Blood 84: 1056-63, 1994.
15. Aoki I., Higashi K., Homori M., Chikazawa H., Ishikawa K.: Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in aplastic anemia and myelodysplastic syndrome. Am. J. Hematol. 35:6-12, 1990.
16. Aoki I, Nishijima K, Homori M, Nakahara K., Higashi K., Ishikawa K.: Responsiveness of bone marrow erythroid progenitors (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in multiple myeloma. Br. J. Haematol. 81:463-9, 1992.
17. Binet J.L., Auquier A., Dighiero G., et al.: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198-206, 1981.
18. Iscove N.N., Sieber F., Winterhalter K.H.: Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirements of erythropoietin by gel filtration and affinity chromatography on agarose concavalin A. J. Cell Physiol. 85:309-320, 1974.
19. Goldman J.M., Hibbin J.A., Kearney L.V., Orchard K., Thing K.M.: HLA-DR monoclonal antibodies inhibit the proliferation of normal and chronic granulocytic leukemia myeloid progenitor cells. Br. J. Haematol. 52:411-420, 1982.
20. Urabe A., Saito H., Fukamachi H., Kubota M., Takaku F.: Serum erythropoietin titers in the anemia of chronic renal failure and other hematologic states. Int. J. Cell Cloning 5: 202-208, 1987.
21. Means R.T., Krantz S.B.: Inhibition of human erythroid colony-forming units by interferon can be corrected by recombinant human erythropoietin. Blood 78:2564-7, 1991.
22. Sawada K., Krantz S.B., Kans J.S., et al.: Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J. Clin. Invest 80:357-66, 1987.
23. D'Andrea A.D., Lodish H.F., Wong G.G.: Expression cloning of the murine erythropoietin receptor. Cell 57:277-85, 1988.
24. Hoshino S., Teramura M., Takahashi M., et al.: Expression and characterization of erytropoietin receptors on normal human bone marrow cells. Int. J. Cell Cloning 7:156-67, 1989.
25. Sawada K., Krantz S.B., Dai C.H., et al.: Purification of human blood burst-forming units erythroid and demonstration of the evolution of erythropoietin receptors. J. Cell Physiol. 142:219-30, 1990.
26. Lindenmann A., Ludwig W.D., Oster W., Mertelsmann R., Hermann F.: High level secretion of tumor necrosis factor alpha contributes to hematopoietic failure in hairy cell leukemia. Blood 73:880-4, 1989.
27. Taniguchi N., Kuratsune H., Kanamaru Y., et al.: Inhibition against CFU-C and CFU-E colony formation by soluble factor(s) derived from hairy cells. Blood 73:907-13, 1989.
28. Michalevicz R., Porat R., Vechoropoulos M., et al.: Resteration of in vitro hematopoiesis in Bchronic Iymphocytic leukemia by antibodies to tumor necrosis factor. Leuk. Res. 15: 111-20, 1991.